RARS1 fusion with MAD1L1 has been reported to stimulate the FUBP1/c-Myc signaling pathway, inducing tumorigenesis in nasopharyngeal carcinoma (Zhong et al., 2018). This evidence concerns the gene RARS1 and nasopharyngeal carcinoma.